DeepMed Research

New Mexico Cancer Care Alliance

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2002-01-01

Employees: 11

Market Cap: -

Website: https://nmcca.org

Clinical Trials

A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes

Phase 3

Completed

Conditions: Supportive
Ill-defined Sites

Interventions: Drug: paclitaxel, docetaxel, taxane
Drug: taxane

First Posted Date: 2006-01-13

Last Posted Date: 2011-09-27

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 200

Registration Number: NCT00277043

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma

Phase 1

Completed

Conditions: Sarcoma

Interventions: Drug: Gemcitabine, Docetaxel and Bevacizumab

First Posted Date: 2006-01-12

Last Posted Date: 2015-06-19

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 38

Registration Number: NCT00276055

Locations: 🇺🇸
Hematology Oncology Associates, Albuquerque, New Mexico, United States
🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States
🇺🇸
St. Vincent Regional Medical Center, Santa Fe, New Mexico, United States

and more 1 locations

Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach

Phase 2

Terminated

Conditions: Non-Hodgkin's Lymphoma
Cancer

Interventions: Drug: Vincristine
Drug: VP-16
Drug: Rituximab
Drug: Dexamethasone
Drug: Levofloxacin

First Posted Date: 2005-11-08

Last Posted Date: 2015-08-03

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 17

Registration Number: NCT00250718

Locations: 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting

Phase 2

Completed

Conditions: Cancer

Interventions: Drug: Aprepitant vs. Gabapentin

First Posted Date: 2005-11-08

Last Posted Date: 2011-09-27

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 200

Registration Number: NCT00250744

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer

Phase 2

Terminated

Conditions: Rectal Cancer

Interventions: Other: Chemotherapy, Celecoxib, and Radiation

First Posted Date: 2005-11-08

Last Posted Date: 2015-09-01

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 38

Registration Number: NCT00250835

Locations: 🇺🇸
Hematology Oncology Associates, Albuquerque, New Mexico, United States
🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
🇺🇸
New Mexico Cancer Care Associates, Santa Fe, New Mexico, United States

Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions

Terminated

Conditions: Prostate Cancer

First Posted Date: 2005-11-08

Last Posted Date: 2016-01-08

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 101

Registration Number: NCT00250757

Locations: 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter

Phase 2

Completed

Conditions: Liver Cancer

First Posted Date: 2005-11-08

Last Posted Date: 2011-10-05

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 11

Registration Number: NCT00250822

Locations: 🇺🇸
Hematology Oncology Associates, Albuquerque, New Mexico, United States
🇺🇸
Lovelace Sandia Health Systems Dept of Hematology, Albuquerque, New Mexico, United States
🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

and more 1 locations

Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen

Not Applicable

Completed

Conditions: Colonic Diseases
Cancer

First Posted Date: 2005-11-07

Last Posted Date: 2011-09-27

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 30

Registration Number: NCT00250029

Locations: 🇺🇸
New Mexico Veterans Administration Health Care System, Albuquerque, New Mexico, United States
🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
🇺🇸
Hematology Oncology Associates, Albuquerque, New Mexico, United States

and more 1 locations

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

Phase 2

Completed

Conditions: Leukemia, Other
Cancer

First Posted Date: 2005-11-07

Last Posted Date: 2011-09-20

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 6

Registration Number: NCT00250042

Locations: 🇺🇸
New Mexico Cancer Care Associates, Santa Fe, New Mexico, United States
🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Clinical Benefit of Topoisomerase Downregulation

Phase 1

Completed

Conditions: Ovarian Cancer

First Posted Date: 2005-11-07

Last Posted Date: 2011-09-07

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 15

Registration Number: NCT00250094

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy